Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis

Arthritis and Rheumatism

Volumn 40, Issue 10, 1997, Pages 1896-1898

  Leipold, G ^a   Schutz E ^b   Haas, J P ^a   Oellerich, M ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AZATHIOPRINE; COTRIMOXAZOLE; DICLOFENAC; GRANULOCYTE COLONY STIMULATING FACTOR; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; BONE MARROW SUPPRESSION; CASE REPORT; ENZYME DEFICIENCY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; PANCYTOPENIA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPONDYLOARTHROPATHY; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS; AZATHIOPRINE; FEMALE; HLA-B27 ANTIGEN; HOMOZYGOTE; HUMANS; METHYLTRANSFERASES; PANCYTOPENIA; POINT MUTATION; SPINAL DISEASES;

EID: 0030871031     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401026     Document Type: Article

References (14)

1. Weinshilboum RM, Raymond FA, Pazmino PA: Human erythrocyte thiopurinc methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85:323-333, 1978
2. Schütz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M: Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine? Ther Drug Monit 18:228-233, 1996
3. Krynetsky EY, Schutz JD, Galpin AJ, Pui CH, Relling MV, Evans WE: A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A 92:949-953, 1995
4. Tai HL, Krynetsky EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, Evans WE: Thiopurinc S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 58:694-702, 1996
5. Szumlanski C, Otterness D, Her C, Lee D, Brandiff B, Kelsell D, Spur N, Lennard L, Wieben E, Weinshillboum R: Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 15:17-30, 1996
6. McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE: Thiopurine methyltransferase activity in American white and black subjects. Clin Pharmacol Ther 55:15-20, 1994
7. Schütz E, Gummert J, Armstrong VW, Mohr FW, Oellerich M: Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation. Eur J Clin Chem Clin Biochem 34:199-205, 1996
8. Vuchetich JP, Weinshilboum RM, Price RA: Segregation analysis of human red blood cell thiopurine methyltransferase activity. Genet Epidemiol 12:1-11, 1995
9. Lennard L, Brown CB, Fox M, Maddocks JL: Azathioprine metabolism in kidney transplant recipients. Br J Clin Pharmacol 18:693-700, 1984
10. Kerstens PJSM, Stolk JN, De Abreu RA, Lambooy LHJ, van de Putte LBA, Boerbooms AAMT: Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum 38:142-145, 1995
11. Szumlanski C, Honchel R, Scott MC, Weinshilboum RM: Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 2:148-159, 1992
12. Evans WE, Horner M, Chu YQ, Kalwinsky D, Roberts M: Altered mercaptopurine metabolism, toxic effects and dosage requirements in a thiopurine methyltransferase deficient child with acute lymphoblastic leukemia. J Pediatr 119:985-989, 1991
13. Kvien TK, Hoyeraal HM, Sandstad B: Azathioprine versus placebo in patients with rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 13:118-123, 1986
14. Chocair PR, Duley JA, Simmonds AH, Cameron JS: The importance of TPMT activity for the use of azathioprine in transplant patients. Transplantation 53:1051-1056, 1992